Following the success of the 4th AI Hardware Summit that took place 13-16th September in Mountain View, US, Kisaco Research is proud to announce the annual 2022 Executive Outlook. The Executive Outlook provides leading industry executives, and key decision makers, an exclusive chance to network, discuss and share their views and predictions on the market from a strategic viewpoint, and, collectively define a vision for the future of AI systems.Our Executive Outlook is an annual, end-of-year executive-level summit and awards ceremony. It will recognize both engineering and business achievements during the year and gather the very best and brightest in the AI acceleration world, to pause and reflect on the year and set a vision for the following 12 months.The forum will consist of analyst overviews and predictions, executive keynotes, and an awards ceremony.The AI Hardware Summit will continue to be the event that brings together the AI acceleration community to put the best AI systems in the hands of the world’s leading scientists, researchers, and enterprises. The AI Hardware Executive Outlook Summit is designed to celebrate this incredible industry and unify its members in a shared vision of the future.Event OverviewThursday December 1, 2021| Online & Broadcasting Globally
Join us as we explore how you can avoid very costly investigations, multi-million civil and criminal penalties, and reputational damage with sanctions compliance officers required to be on top of crucial new developments, and to benchmark and re-evaluate compliance risks and priorities.With the latest geopolitical shakeups, rapid technological disruptions, and the nature of sanctions (an already massive regulatory compliance minefield for multinationals) evolving in complexity and extra-territorial outreach in 2023, EU Commission, OFAC, and other enforcement bodies are expected to step up and sharpen their enforcement actions and extend their reach in terms of both scope and severity, making it essential for you to be on top of your sanctions and export controls strategy..
Earlier detection of disease can revolutionise patient outcomes for a variety of therapeutic areas, significantly reducing mortality rates of diseases such as cancer.The first of its kind to approach early detection from a cross-disease focus, the Early Detection Summit provides the latest case studies and innovative strategies enabling accelerating early detection – from cancer, to diabetes, to arthritis.Gain insights from leading pharma, biotech companies and academic researchers facilitating the new age of early detection tools, with a lens on collaborative working to advance research forward.
One Week of Specialist Webinars for The Legal & Compliance Community to Gain International Legal Updates, Mitigate Regulatory Risks and Enhance Internal Efficiency.
Join us at the International Phage Futures Congress in 2021, as we create a virtual stage upon which to initiate all-important discussions & forge partnerships between key stakeholders from all over the world. Experts in their respective fields will discuss how to translate new phage-based applications into clinical studies & beyond.Discover how you can be at the forefront of the developing phage therapy market.Network & learn from established biotech companies, emerging start-ups, leading academics, global accelerator representatives, investment firms, international healthcare organisations & regulatory bodies. Among other topics, expect to hear & participate in:Advice on how to successfully navigate clinical trial progression to prove efficacy along with recent developments from leading biotechs in phage therapeutic trials targeting chronic & acute illnesses.Regulatory discussions between international governing bodies with region specific follow-up conversations with the experts.Insights into new fields for phage application, such as oncology, diagnostics & microbial gene therapy.Expert advice on how to find & secure financial investments.
Protein degradation has redefined the drug discovery landscape, offering a promising solution in the quest to ‘drug the undruggable’. Whilst over the past few years this field as witnessed unprecedented growth, investment, and intrigue (around €4 billion worth, to be precise), 2021 is set to be another showstopper for targeted protein degradation with 15 compounds predicted to enter the clinic by the end of the year.As we enter a new wave of drug discovery:Explore the clinical viability of protein degraders including discussions on delivery methods, optimisation strategies and DMPK & SAR parametersLearn how multispecifics that form connections between POIs and cellular machinery are expanding drug amenability of proteins in this untapped, new wave of medicine.Reach “undruggable” high-hanging fruit using chemoproteomics platforms including DNA encoded libraries and covalent ligand discovery
Join us online at Phage Futures: Global Digital Summit 2023 as we create a virtual stage upon which to initiate all-important discussions and forge partnerships between key stakeholders from all over the world. Experts in their respective fields will discuss how to translate new phage-based applications into clinical studies and beyond.Discover how you can be at the forefront of the developing phage therapy market.Network and learn from established biotech companies, emerging start-ups, leading academics, global accelerator representatives, investment firms, international healthcare organisations and regulatory bodies.Key topics to hear and participate in:Advice on how to successfully navigate clinical trial progression to prove efficacy along with recent developments from leading biotechs in phage therapeutic trials targeting chronic and acute illnessesRegulatory discussions between international governing bodies with region specific follow-up conversations with the expertsThe latest clinical data from the leading pharma and biotech companies in the industryExpert advice on how to find and secure financial investmentsBOOK YOUR FREE PASS HERE
The opportunity of Edge AI is clear - it is bringing real-time, personalized, scalable, and secure AI to resource constrained devices, unlocking the next wave of intelligent devices.Optimizing AI performance whilst operating economically at the edge remains the elusive holy grail. For four years, the Edge AI Summit has aided enterprise adopters, OEMs, AI software, and hardware providers in their pursuit of deploying AI at the edge, by helping them form partnerships that will improve the performance of embedded hardware, optimize models, and compress workloads to enable high-performing and low-footprint AI to exist at the edge.The 4th Annual Edge AI Summit (November 15-18, virtually) unites the technologists from around the world tasked with designing and developing real-world use cases that bring real-time and secure AI to low-power applications from the sensor-edge to device-edge, and to areas that have limited connectivity to the cloud.
Showcasing the Most Exciting Innovation Across Nutrition, Health and Digital The Aquaculture Innovation Summit is back! Now in its 4th year, the Summit is a major part of the Animal Health Innovation series, which focuses on showcasing and supporting innovation and sustainability initiatives in three key areas of aquaculture: nutrition, health and digital.Our objective at this two-day event is to bring to light cutting-edge modern technologies and solutions that are helping shape one of the most important industries for the future of global protein. Throughout the on-demand and live parts of the agenda, key discussions in 2021 include:Digital transformation and how that can optimise aquacultureIdentifying the next steps to guarantee the future of sustainable and functional feedsThe hottest areas for investment from investors and big companiesThe future of health and genetics to improve performance and welfareEnsuring aquaculture is seen as part of a healthy, sustainable food systemDeep dive into land-based and open ocean as alternatives to in-shore, cage-based production
